Jinwon Life Sciences Signs Plasmid DNA Supply Contract Worth $3.6 Million

Jinwon Life Sciences announced on the 24th that it has signed a plasmid DNA pharmaceutical supply contract worth 3.6 million USD with a US biotech company.

A company representative explained, "The name of the contracting party cannot be disclosed due to a confidentiality clause in the contract, and when converted to Korean won, the contract amount is approximately 5 billion KRW."

Park Young-geun, CEO of Jinwon Life Sciences, stated, "As the development of cell and gene therapies expands, the demand for plasmid DNA is increasing, so based on the high-quality plasmid DNA supply capabilities of our subsidiary VGXI, we expect continuous orders."